The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: A local experience

Pathology and Oncology Research

Volumn 15, Issue 2, 2009, Pages 257-267

  Bagheri, Kambiz ^a   Alimoghadam, Kamran ^b   Pourfathollah, Ali Akbar ^a   Hassan, Zuhair Muhammad ^a   Hajati, Jamshid ^c   Moazzeni, Seyyed Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dendritic cell; Differentiation; Immunotherapy; Iranian AML patients; Leukemia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 4; RECOMBINANT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IRAN; LYMPHOCYTE PROLIFERATION; MALE; PROTEIN EXPRESSION; T LYMPHOCYTE; ANTIGEN PRESENTING CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; TUMOR CELL CULTURE;

ADULT; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 68949110286     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9105-1     Document Type: Article

References (54)

1. ZY Wang Z Chen 2008 Acute promyelocytic leukemia: from highly fatal to highly curable Blood 111 2505 2515 10.1182/blood-2007-07-102798 1:CAS:528:DC%2BD1cXivFaktrg%3D 18299451
2. AR Mato A Morgans SM Luger 2008 Novel strategies for relapsed and refractory acute myeloid leukemia Curr Opin Hematol 15 108 114 10.1097/MOH.0b013e3282f463d2 18300756 (Pubitemid 351323150)
3. M Capra L Vilella WV Pereira VM Coser MS Fernandes MA Schilling D Almeida M Gross M Leite T Hellwig G Natchigal A Zelmanowicz G Paskulin J Neumann L Silla 2007 Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil Leuk Lymphoma 48 2381 2386 10.1080/10428190701713622 18067014 (Pubitemid 350253469)
4. D Pulte A Gondos H Brenner 2008 Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century Haematologica 93 594 600 10.3324/haematol.12304 18322250
5. M Yanada G Garcia-Manero G Borthakur F Ravandi H Kantarjian E Estey 2008 Relapse and death during first remission in acute myeloid leukemia Haematologica 93 633 634 10.3324/haematol.12366 18379012 (Pubitemid 351559358)
6. HR Kim JH Shin JN Lee EY Lee 2007 Clinical significance of quantitation of WT1 gene expression for minimal residual disease monitoring of acute myelogenous leukemia Korean J Lab Med 27 305 312 10.3343/kjlm.2007.27.5.305 1:CAS:528:DC%2BD2sXhsVSjtbzJ 18094593
7. MM Ho DE Hogge V Ling 2008 MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia Exp Hematol 36 433 442 10.1016/j.exphem.2007.11.014 1:CAS:528:DC%2BD1cXjtl2ksr8%3D 18249061
8. K Hussein B Jahagirdar P Gupta L Burns K Larsen D Weisdorf 2008 Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia Am J Hematol 83 6 446 450 10.1002/ajh.21133 18247382 (Pubitemid 351742790)
9. HB Ommen CG Nyvold K Braendstrup BL Andersen IB Ommen H Hasle P Hokland M Ostergaard 2008 Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals Br J Haematol 141 6 782 791 10.1111/j.1365-2141. 2008.07132.x 1:CAS:528:DC%2BD1cXotlCru7w%3D 18410450 (Pubitemid 351724866)
10. F Aversa 2008 Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States Bone Marrow Transplant 41 473 481 10.1038/sj.bmt.1705966 1:STN:280: DC%2BD1c7nsVOmsg%3D%3D 18176612
11. M Hamadani FT Awan EA Copelan 2008 Hematopoietic stem cell transplantation in adults with acute myeloid leukemia Biol Blood Marrow Transplant 14 556 567 10.1016/j.bbmt.2008.02.019 1:CAS:528:DC%2BD1cXmtFSns7k%3D 18410898
12. A Fefer KM Sullivan P Weiden CD Buckner G Schoch R Storb ED Thomas 1987 Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation Prog Clin Biol Res 244 401 408 1:STN:280:DyaL1c%2Fhs1Cgtw%3D%3D 3310002
13. XJ Huang Y Wang DH Liu LP Xu H Chen YH Chen W Han HX Shi KY Liu 2008 Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia-feasibility and safety study J Clin Immunol 28 390 397 10.1007/s10875-008-9193-4 1:CAS:528:DC%2BD1cXot1Wksbo%3D 18347959
14. S Slavin A Ackerstein E Naparstek R Or L Weiss 1990 The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD? Bone Marrow Transplant 6 155 161 1:STN:280:DyaK3M%2FntVWgtQ%3D%3D 2252954
15. X Ge J Brown M Sykes VA Boussiotis 2008 CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors Biol Blood Marrow Transplant 14 518 530 10.1016/j.bbmt.2008.02.010 1:CAS:528:DC%2BD1cXmtFSns7o%3D 18410894
16. UF Hartwig M Nonn S Khan I Link C Huber W Herr 2008 Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity Biol Blood Marrow Transplant 14 99 109 10.1016/j.bbmt.2007.10.002 1:CAS:528: DC%2BD1cXhs12hsLk%3D 18158966 (Pubitemid 350286744)
17. AG Buggins D Milojkovic MJ Arno NC Lea GJ Mufti NS Thomas WJ Hirst 2001 Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways J Immunol 167 6021 6030 1:CAS:528:DC%2BD3MXotlalsrk%3D 11698483
18. M Narita M Takahashi A Liu K Nikkuni T Furukawa K Toba S Koyama K Takai M Sanada Y Aizawa 2001 Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia Exp Hematol 29 709 719 10.1016/S0301-472X(01)00636-1 1:STN:280:DC%2BD3M3pslCjtQ%3D%3D 11378266 (Pubitemid 32500372)
19. JK Orleans-Lindsay LD Barber HG Prentice MW Lowdell 2001 Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function-implications for the adoptive immunotherapy of leukaemia Clin Exp Immunol 126 403 411 10.1046/j.1365-2249. 2001.01692.x 1:CAS:528:DC%2BD38XltVejtQ%3D%3D 11737054 (Pubitemid 34008710)
20. D Duluc Y Delneste F Tan MP Moles L Grimaud J Lenoir L Preisser I Anegon L Catala N Ifrah P Descamps E Gamelin H Gascan M Hebbar P Jeannin 2007 Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells Blood 110 4319 4330 10.1182/blood-2007-02-072587 1:CAS:528:DC%2BD1cXot1Si 17848619
21. N Hirano T Takahashi S Ohtake K Hirashima N Emi K Saito M Hirano K Shinohara M Takeuchi F Taketazu S Tsunoda M Ogura M Omine T Saito Y Yazaki R Ueda H Hirai 1996 Expression of costimulatory molecules in human leukemias Leukemia 10 1168 1176 1:STN:280:DyaK283otlGrtA%3D%3D 8683998
22. RT Costello F Mallet D Sainty D Maraninchi JA Gastaut D Olive 1998 Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition Eur J Immunol 28 90 103 10.1002/(SICI)1521-4141(199801)28:01<90::AID-IMMU90>3.0.CO;2-5 1:CAS:528:DyaK1cXpvVyjug%3D%3D 9485189 (Pubitemid 28048280)
23. O Bruserud 1999 Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies Leukemia 13 1175 1187 10.1038/sj/leu/2401452 1:CAS:528: DyaK1MXlvVOiurw%3D 10450745
24. S Adams DW O'Neill N Bhardwaj 2005 Recent advances in dendritic cell biology J Clin Immunol 25 87 98 10.1007/s10875-005-2814-2 15821885 (Pubitemid 40576720)
25. J Greiner H Dohner M Schmitt 2006 Cancer vaccines for patients with acute myeloid leukemia-definition of leukemia-associated antigens and current clinical protocols targeting these antigens Haematologica 91 1653 1661 1:CAS:528:DC%2BD2sXptlemug%3D%3D 17145602
26. M Heinzinger CF Waller A von den Berg A Rosenstiel W Lange 1999 Generation of dendritic cells from patients with chronic myelogenous leukemia Ann Hematol 78 181 186 10.1007/s002770050497 1:CAS:528:DyaK1MXisV2ltLc%3D 10348149 (Pubitemid 29201729)
27. K Eisendle A Lang B Eibl D Nachbaur H Glassl M Fiegl J Thaler G Gastl 2003 Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia Br J Haematol 120 63 73 10.1046/j.1365-2141.2003.03979.x 12492578 (Pubitemid 36056910)
28. T Takahashi Y Tanaka M Nieda T Azuma S Chiba T Juji Y Shibata H Hirai 2003 Dendritic cell vaccination for patients with chronic myelogenous leukemia Leuk Res 27 795 802 10.1016/S0145-2126(03)00011-0 12804637 (Pubitemid 36683326)
29. Tong XM, Jin J, Qian WB, Meng HT, Xue YQ (2005) Biological features of dendritic cells derived from chronic myeloid leukemia cells in vitro. Zhejiang Da Xue Xue Bao Yi Xue Ban 34:348-352, 357
30. YF Zhang CY Wu LS Zhang Y Chai 2006 In vitro cytokines-induced differentiation in mononuclear cell derived dendritic cells from chronic myeloid leukemia Zhongguo Shi Yan Xue Ye Xue Za Zhi 14 137 141 1:CAS:528: DC%2BD2sXlsVegtLc%3D 16584610
31. T Kohler R Plettig W Wetzstein M Schmitz M Ritter B Mohr U Schaekel G Ehninger M Bornhauser 2000 Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells Stem Cells 18 139 147 10.1634/stemcells.18-2-139 1:STN:280: DC%2BD3c3gvFSqsg%3D%3D 10742386
32. L Oehler A Berer M Kollars F Keil M Konig M Waclavicek O Haas W Knapp K Lechner K Geissler 2000 Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia Ann Hematol 79 355 362 10.1007/s002770000159 1:CAS:528:DC%2BD3cXksFGhtrg%3D 10965783 (Pubitemid 30459660)
33. D Claxton A Choudhury 2001 Potential for therapy with AML-derived dendritic cells Leukemia 15 668 669 10.1038/sj/leu/2402056 1:STN:280: DC%2BD3M3ntVegsQ%3D%3D 11368375 (Pubitemid 32266741)
34. KH Yan SG You SG Bian GJ Ma W Ge S Ma SH Liu CH Zhao 2003 Dendritic cells (DC) induced from acute myeloid leukemia (AML) cells with cytokine cocktails Zhonghua Xue Ye Xue Za Zhi 24 365 368 12941192
35. I Houtenbos TM Westers GJ Ossenkoppele AA van de Loosdrecht 2006 Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia Haematologica 91 348 355 16531258
36. SP Robinson N English R Jaju L Kearney SC Knight CD Reid 1998 The in-vitro generation of dendritic cells from blast cells in acute leukaemia Br J Haematol 103 763 771 1:STN:280:DyaK1M%2Fntl2guw%3D%3D 9858228
37. BA Choudhury JC Liang EK Thomas L Flores-Romo QS Xie K Agusala S Sutaria I Sinha RE Champlin DF Claxton 1999 Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses Blood 93 780 786 1:CAS:528:DyaK1MXpsFOquw%3D%3D 9920826
38. RE Brouwer M van der Hoorn HC Kluin-Nelemans S van Zelderen-Bhola R Willemze JH Falkenburg 2000 The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses Hum Immunol 61 565 574 10.1016/S0198-8859(00)00111-7 1:CAS:528:DC%2BD3cXjsVGjur8%3D 10825585 (Pubitemid 30346483)
39. BD Harrison JA Adams M Briggs ML Brereton JA Yin 2001 Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia Blood 97 2764 2771 10.1182/blood.V97.9.2764 1:CAS:528:DC%2BD3MXjtlSiu7g%3D 11313269
40. PH Roddie Y Horton ML Turner 2002 Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1 Leukemia 16 84 93 10.1038/sj.leu.2402335 1:CAS:528:DC%2BD38Xht1yrsrk%3D 11840267
41. B Almand JR Resser B Lindman S Nadaf JI Clark ED Kwon DP Carbone DI Gabrilovich 2000 Clinical significance of defective dendritic cell differentiation in cancer Clin Cancer Res 6 1755 1766 1:STN:280: DC%2BD3cvhtVOhsw%3D%3D 10815894
42. C Bello-Fernandez J Stasakova A Renner N Carballido-Perrig M Koening M Waclavicek O Madjic L Oehler O Haas JM Carballido M Buschle W Knapp 2003 Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties Blood 101 2184 2190 10.1182/blood-2002-02-0378 1:CAS:528:DC%2BD3sXit1egsL0%3D 12424204 (Pubitemid 36302056)
43. E Orsini A Guarini S Chiaretti FR Mauro R Foa 2003 The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response Cancer Res 63 4497 4506 1:CAS:528:DC%2BD3sXmtFersrc%3D 12907623
44. HJ Van der Reijden DJ van Rhenen PM Lansdorp MB van't Veer MM Langenhuijsen CP Engelfriet AE von dem Borne 1983 A comparison of surface marker analysis and FAB classification in acute myeloid leukemia Blood 61 443 448 6572076
45. PB Neame P Soamboonsrup GP Browman RM Meyer A Benger WE Wilson IR Walker N Saeed JA McBride 1986 Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML Blood 68 1355 1362 1:STN:280:DyaL2s%2FltVSmsQ%3D%3D 3465377
46. SM Danilov E Sadovnikova N Scharenborg IV Balyasnikova DA Svinareva EL Semikina EN Parovichnikova VG Savchenko GJ Adema 2003 Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells Exp Hematol 31 1301 1309 10.1016/j.exphem.2003.08.018 1:CAS:528:DC%2BD3sXps1yjtrY%3D 14662338 (Pubitemid 37510036)
47. L Conti M Cardone B Varano P Puddu F Belardelli S Gessani 2008 Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes Eur J Immunol 38 750 762 10.1002/eji.200737395 1:CAS:528:DC%2BD1cXjsVansrs%3D 18236400
48. HT Hassan A Zander 1996 Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis Acta Haematol 95 257 262 10.1159/000203893 1:CAS:528:DyaK28XktF2ktL4%3D 8677752
49. C Caux S Saeland C Favre V Duvert P Mannoni J Banchereau 1990 Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells Blood 75 2292 2298 1:CAS:528: DyaK3cXkslKhurY%3D 1693526
50. A Mackensen B Herbst JL Chen G Kohler C Noppen W Herr GC Spagnoli V Cerundolo A Lindemann 2000 Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells Int J Cancer 86 385 392 10.1002/(SICI)1097-0215(20000501)86: 3<385::AID-IJC13>3.0.CO;2-T 1:CAS:528:DC%2BD3cXivVyjurc%3D 10760827
51. C Brunner J Seiderer A Schlamp M Bidlingmaier A Eigler W Haimerl HA Lehr AM Krieg G Hartmann S Endres 2000 Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo J Immunol 165 6278 6286 1:CAS:528:DC%2BD3cXosFOiu7Y%3D 11086063
52. Y Morel A Truneh RW Sweet D Olive RT Costello 2001 The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity J Immunol 167 2479 2486 1:CAS:528:DC%2BD3MXmtlSjsb0%3D 11509586
53. A Cignetti E Bryant B Allione A Vitale R Foa MA Cheever 1999 CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells Blood 94 2048 2055 1:CAS:528:DyaK1MXlvFCmsrs%3D 10477734
54. K Bagheri N Delirezh SM Moazzeni 2008 PPD extract induces the maturation of human monocyte-derived dendritic cells Immunopharmacol Immunotoxicol 30 91 104 10.1080/08923970701812654 18306107 (Pubitemid 351311969)